Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.90
Bid: 297.20
Ask: 297.40
Change: -5.40 (-1.79%)
Spread: 0.20 (0.067%)
Open: 301.70
High: 302.90
Low: 295.20
Prev. Close: 302.30
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

10 Jan 2012 07:00

RNS Number : 2753V
Marks & Spencer Group PLC
10 January 2012
 



10 January 2012

 

MARKS AND SPENCER GROUP PLC

QUARTER 3 2011/12 - INTERIM MANAGEMENT STATEMENT

13 weeks to 31 December 2011

 

'Marks & Spencer performs well in a challenging trading environment'

 

·; Group sales ex VAT +2.4%

·; Total UK sales ex VAT +1.8%: General Merchandise -0.8%, Food +4.5%

·; Like for like UK sales ex VAT +0.5%: General Merchandise -1.8%, Food +3.0%

·; Direct sales ex VAT +22.4%

·; International sales +8.1%

 

Marc Bolland, Chief Executive said:

"Marks & Spencer performed well in a challenging trading environment.

 

"Our Food business performed very strongly as customers enjoyed our new and traditional Christmas products. This unique offer, coupled with our great deals, gave them more choice than ever before for a special Christmas at home.

 

"In Clothing our focus was on offering our customers real value at a time when they're managing their budgets carefully. Our trading strategy worked well, delivering a record performance in many categories including menswear and sleepwear.

 

"I would like to take this opportunity to thank all of our employees for their hard work in delivering a great Christmas for our customers."

 

Trading summary

Clothing sales were up 1.1% as we continued to invest in offering our customers even better value. Customers continued to recognise our leading quality, resulting in our biggest ever quarter in kidswear.

 

Home sales were down 13.3%, primarily impacted by our decision to exit technology. Our key focus departments performed well, and the planned roll-out of new ranges and store layout later this year will provide a step change in our Home offer.

 

Food sales were up 4.5%, with customers choosing to protect their spending on festive food, despite the pressure on their disposable incomes. We offered an exciting range of seasonal products with more choice than ever before, introducing 600 new lines, including our best selling party food and dessert ranges.

 

Direct delivered a strong performance with sales up 22.4%. We made it even more convenient for our customers to shop with us through the extension of the next day delivery deadline and the launch of our Christmas Food to Order service on-line, which contributed to a 12% increase in orders.

 

International sales were up 8.1%, reflecting continued growth in the priority markets of India and Shanghai, as well as in our franchise business. We had a very good start to our newly opened flagship store in Paris.

  

Guidance

Our expectations for full year profit remain unchanged. Our decision to invest in promotions in General Merchandise will result in lower gross margin compared to previous guidance, but this will be off-set by additional savings generated by on-going tight management of costs.

 

Outlook

In light of the ongoing macro-economic uncertainty, we expect trading conditions to remain challenging. We continue to be cautious about the outlook for the year ahead. Our focus will be on offering our customers great value and quality at a time when they are managing their budgets carefully.

Marks and Spencer Group plc will report its fourth quarter trading statement for the 13 weeks ending 31 March 2012, on 17 April 2012.

 

 

Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences and prospects are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect Marks & Spencer's current expectations concerning future events and actual results may differ materially from current expectations or historical results. Any such forward-looking statements are subject to various risks and uncertainties, including failure by Marks & Spencer to predict accurately customer preferences; decline in the demand for products offered by Marks & Spencer; competitive influences; changes in levels of store traffic or consumer spending habits; effectiveness of Marks & Spencer's brand awareness and marketing programmes; general economic conditions or a downturn in the retail or financial services industries; acts of war or terrorism worldwide; work stoppages, slowdowns or strikes; and changes in financial and equity markets.

 

Contacts

Investor Relations:

Majda Rainer +44 (0)20 8718 1563

Richard Harris +44 (0)20 8718 9688

 

Corporate Press Office: +44 (0)20 8718 1919

Out of hours calls: +44 (0)20 8718 2000

 

Investors & Analysts Conference Call:

This will be hosted by Marc Bolland at 08:45am on Tuesday 10 January 2012:

 

Dial in number: +44 (0)20 8515 2302

A recording of this call will be available until 20 January 2012:

 

Dial in number: +44 (0)20 7959 6720

Access Code: 4502117#

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMGMMVGLGZZG
Date   Source Headline
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.